Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005111119 | SCV005731212 | pathogenic | Bethlem myopathy 1A | 2025-01-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val824Serfs*17) in the COL6A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL6A3 are known to be pathogenic (PMID: 26004199). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with COL6A3-related conditions. For these reasons, this variant has been classified as Pathogenic. |